Previous studies have highlighted the importance of both CD38 enzymatic and receptor function for CLL BCR signaling; however, it is unclear how they mechanistically regulate BCR signaling and proliferation in CLL. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.